King Pharmaceuticals KG Benefits, Losses and Expenses, Net
Benefits, Losses and Expenses, Net at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:BenefitsLossesAndExpensesNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's benefits, losses and expenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's benefits, losses and expenses, net?
- King Pharmaceuticals (KG) reported benefits, losses and expenses, net of $17.14M in Q1 2026.
- How has King Pharmaceuticals's benefits, losses and expenses, net changed year-over-year?
- King Pharmaceuticals's benefits, losses and expenses, net increased by 1399.5% year-over-year, from $1.14M to $17.14M.
- What does benefits, losses and expenses, net mean?
- This metric represents the aggregate net impact of insurance-related claims, underwriting expenses, and other operational costs incurred during the reporting period. It serves as a comprehensive measure of the total cost structure associated with generating insurance revenue, adjusted for non-operating gains or losses. Investors use this to evaluate the overall efficiency of the company's core underwriting and administrative operations.